pathology labs ltd Company Information
Company Number
12524300
Next Accounts
Dec 2025
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Shareholders
samir al hyassat
kamaran kakel
Group Structure
View All
Contact
Registered Address
c/o agp consulting q west, great west road, brentford, TW8 0GP
Website
pathkindlabs.compathology labs ltd Estimated Valuation
Pomanda estimates the enterprise value of PATHOLOGY LABS LTD at £0 based on a Turnover of £0 and 0.6x industry multiple (adjusted for size and gross margin).
pathology labs ltd Estimated Valuation
Pomanda estimates the enterprise value of PATHOLOGY LABS LTD at £0 based on an EBITDA of £0 and a 4.37x industry multiple (adjusted for size and gross margin).
pathology labs ltd Estimated Valuation
Pomanda estimates the enterprise value of PATHOLOGY LABS LTD at £4 based on Net Assets of £2 and 2.22x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pathology Labs Ltd Overview
Pathology Labs Ltd is a live company located in brentford, TW8 0GP with a Companies House number of 12524300. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in March 2020, it's largest shareholder is samir al hyassat with a 50% stake. Pathology Labs Ltd is a startup, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pathology Labs Ltd Health Check
There is insufficient data available to calculate a health check for Pathology Labs Ltd. Company Health Check FAQs
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Pathology Labs Ltd
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Pathology Labs Ltd
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Pathology Labs Ltd
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Pathology Labs Ltd
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Pathology Labs Ltd
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Pathology Labs Ltd
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Pathology Labs Ltd
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Pathology Labs Ltd
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Pathology Labs Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Pathology Labs Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Pathology Labs Ltd
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Pathology Labs Ltd
- - Industry AVG
PATHOLOGY LABS LTD financials
Pathology Labs Ltd's latest turnover from March 2024 is estimated at 0 and the company has net assets of £2. According to their latest financial statements, we estimate that Pathology Labs Ltd has no employees and maintains cash reserves of £2 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
---|---|---|---|---|
Turnover | ||||
Other Income Or Grants | ||||
Cost Of Sales | ||||
Gross Profit | ||||
Admin Expenses | ||||
Operating Profit | ||||
Interest Payable | ||||
Interest Receivable | ||||
Pre-Tax Profit | ||||
Tax | ||||
Profit After Tax | ||||
Dividends Paid | ||||
Retained Profit | ||||
Employee Costs | ||||
Number Of Employees | ||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 |
Total Fixed Assets | 0 | 0 | 0 | 0 |
Stock & work in progress | 0 | 0 | 0 | 0 |
Trade Debtors | 0 | 0 | 0 | 0 |
Group Debtors | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 |
Cash | 2 | 2 | 2 | 2 |
misc current assets | 0 | 0 | 0 | 0 |
total current assets | 2 | 2 | 2 | 2 |
total assets | 2 | 2 | 2 | 2 |
Bank overdraft | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 |
total current liabilities | 0 | 0 | 0 | 0 |
loans | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 |
total liabilities | 0 | 0 | 0 | 0 |
net assets | 2 | 2 | 2 | 2 |
total shareholders funds | 2 | 2 | 2 | 2 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
---|---|---|---|---|
Operating Activities | ||||
Operating Profit | ||||
Depreciation | 0 | 0 | 0 | 0 |
Amortisation | 0 | 0 | 0 | 0 |
Tax | ||||
Stock | 0 | 0 | 0 | 0 |
Debtors | 0 | 0 | 0 | 0 |
Creditors | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||
Investing Activities | ||||
capital expenditure | ||||
Change in Investments | 0 | 0 | 0 | 0 |
cash flow from investments | ||||
Financing Activities | ||||
Bank loans | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 |
share issue | ||||
interest | ||||
cash flow from financing | ||||
cash and cash equivalents | ||||
cash | 0 | 0 | 0 | 2 |
overdraft | 0 | 0 | 0 | 0 |
change in cash | 0 | 0 | 0 | 2 |
pathology labs ltd Credit Report and Business Information
Pathology Labs Ltd Competitor Analysis
Perform a competitor analysis for pathology labs ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other startup companies, companies in TW8 area or any other competitors across 12 key performance metrics.
pathology labs ltd Ownership
PATHOLOGY LABS LTD group structure
Pathology Labs Ltd has no subsidiary companies.
Ultimate parent company
PATHOLOGY LABS LTD
12524300
pathology labs ltd directors
Pathology Labs Ltd currently has 2 directors. The longest serving directors include Dr Samir Al Hyassat (Mar 2020) and Mr Kamaran Kakel (Mar 2020).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Samir Al Hyassat | England | 49 years | Mar 2020 | - | Director |
Mr Kamaran Kakel | United Kingdom | 55 years | Mar 2020 | - | Director |
P&L
March 2024turnover
0
0%
operating profit
-0.1
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
2
0%
total assets
2
0%
cash
2
0%
net assets
Total assets minus all liabilities
Similar Companies
pathology labs ltd company details
company number
12524300
Type
Private limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
March 2020
age
4
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
c/o agp consulting q west, great west road, brentford, TW8 0GP
Bank
-
Legal Advisor
-
pathology labs ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pathology labs ltd.
pathology labs ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PATHOLOGY LABS LTD. This can take several minutes, an email will notify you when this has completed.
pathology labs ltd Companies House Filings - See Documents
date | description | view/download |
---|